跳至主要内容
临床试验/NCT03186443
NCT03186443Unknown3 期

Prevention Effect of Pregabalin on Postherpetic Neuralgia: A Multicenter, Randomized, Double-blind, Controlled Trial

Second Affiliated Hospital of Guangzhou Medical University1 个研究点 分布在 1 个国家目标入组 342 人开始时间: 2017年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
342
试验地点
1
主要终点
the changes of numerical rating scale (NRS)

研究概览

简要总结

Pregabalin is effective on herpetic neuralgia, but whether can prevention post-herpetic neuralgia still need to confirm.

详细描述

Pregabalin has been recommended as the first-line drug for post-herpetic neuralgia (PHN) therapy currently due to its efficacy and safety. However,there was no valuable report at present on the clinical efficacy of pregabalin for acute and subacute herpetic neuralgia (SHN), expect for a smaller study which included 29 outpatients who had acute zoster pain for a period of 7-1 4 days. And it is not clear whether early application of pregabalin can reduce the incidence of PHN.

Therefore, this study was rational designed to evaluate the efficacy and safety of pregabalin in the treatment of herpetic neuralgia,and follow-up to the 8 months, evaluation whether impacting the accidence of PHN.

It is the first time in the international that treating acute herpetic neuralgia (AHN) and SHN with pregabalin as a large sample size clinical trial. The results of this study will be great significance for guiding the clinical medication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pain occurs within 90 days of rash onset
  • Numerical rating scale (NRS) greater than 50 mm

排除标准

  • Patient with nervous system disorders which impair completing the pain diaries
  • Patient with history of illicit drug or alcohol abuse within the last 2 years

研究组 & 干预措施

pregabalin

Active Comparator

experiment group: pregabalin 300mg,q12h for 6 months

干预措施: Pregabalin (Drug)

gabapentin

Experimental

compared to pregabalin effect on herpetic neuralgia

干预措施: Gabapentin (Drug)

结局指标

主要结局

the changes of numerical rating scale (NRS)

时间窗: from the date of start to 8 month

Pain intensity was rated on an 1 1-point numerical rating scale

次要结局

  • Brief Pain Inventory (BPI)(baseline and 8th month)

研究者

发起方
Second Affiliated Hospital of Guangzhou Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验